BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Drug Development

  A Look at BioMarin’s Potential Blockbuster and the Science Behind It All

  October 21, 2016

   · 

  1 min read
• Biotech Bay

  The Other Side: The Patients Hurt by Theranos’ Botched Blood Tests

  October 21, 2016

   · 

  1 min read
• Biotech Bay

  Roche Bets On New Cancer Drugs To Offset Patent Expiries

  October 21, 2016

   · 

  1 min read
• An Online Vision-Test Startup Is Suing For The Right To Operate, Opternative Reveals

  October 21, 2016

   · 

  1 min read
• Biotech Bay

  VCs Cannot Alone Fund Expensive Medical Device Innovations

  October 21, 2016

   · 

  1 min read
• Deals

  CRISPR’s Surprisingly Low IPO… Why Are Investors Discouraged?

  October 21, 2016

   · 

  1 min read
• 

  Job Trends

  295 Sumitomo Dainippon Pharma Employees Take Early Retirement

  October 21, 2016

   · 

  2 min read
• 

  Genetown

  Bernie Sanders Demands Info on Ariad’s Leukemia Drug

  October 21, 2016

   · 

  3 min read
• 

  Bio NC

  4 Biotech Stocks on the Brink of a Major Breakthrough

  October 21, 2016

   · 

  4 min read
• 

  Drug Development

  Study Stopped Early as Merck & Co.'s Immunotherapy Drug Wows in Bladder Cancer Trial

  October 21, 2016

   · 

  2 min read